Activation of vascular endothelial growth factor (VEGF) by the ER-α variant, ERΔ3

Breast Cancer Research and Treatment

Volumn 95, Issue 1, 2006, Pages 37-43

  Koduri, Sailaja ^a,c   Goldhar, Anita S ^b   Vonderhaar, Barbara K ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BIOQUAL INC   (United States)

Author keywords

Estrogen; Estrogen receptor alpha variant; Transcription factor; Vascular endothelial growth factor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; LUCIFERASE; RECEPTOR SUBTYPE; TAMOXIFEN; TRANSCRIPTION FACTOR SP1; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CHO CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EXON; FEMALE; GENE CONSTRUCT; GENE DELETION; GENE INDUCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELLS, CULTURED; CHO CELLS; CRICETINAE; ESTROGEN RECEPTOR ALPHA; EXONS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MUTAGENESIS, SITE-DIRECTED; PLASMIDS; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 32544447924     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9028-4     Document Type: Article

References (39)

1. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1(1): 27-31, 1995 (Review)
2. Battegay EJ: Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73(7): 333-346, 1995 (Review)
3. Weidner N: Intratumoral vascularity as a prognostic factor in cancers of the urogenital tract. Eur J Cancer 32A(14): 2506-2512, 1996
4. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN: Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81(8): 3112-3118, 1996
5. Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M: Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 2(2): 167-182, 1998
6. Ruohola JK, Valve EM, Karkkainen MJ, Joukov V, Alitalo K, Harkonen PL: Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 25; 149(1-2): 29-40, 1999
7. Gasparini G, Toi M, Gion M, Verderio P, Dittadi R, Hanatani M, Matsubara I, Vinante O, Bonoldi E, Boracchi P, Gatti C, Suzuki H, Tominaga T: Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J Natl Cancer Inst 15; 89(2): 139-147, 1997
8. Guidi AJ, Abu-Jawdeh G, Berse B, Jackman RW, Tognazzi K, Dvorak HF, Brown LF: Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. J Natl Cancer Inst 87(16): 1237-1245, 1995
9. Santin AD, Hermonat PL, Ravaggi A, Cannon MJ, Pecorelli S, Parham GP: Secretion of vascular endothelial growth factor in ovarian cancer. Eur J Gynaecol Oncol 20(3): 177-181, 1999
10. Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, Holland JF, Kirschenbaum A: Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology 139(11): 4672-4678, 1998
11. Toi M, Hoshina S, Takayanagi T, Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85(10): 1045-1049, 1994
12. Ludovini V, Sidoni A, Pistola L, Bellezza G, De Angelis V, Gori S, Mosconi AM, Bisagni G, Cherubini R, Bian AR, Rodino C, Sabbatini R, Mazzocchi B, Bucciarelli E, Tonato M, Colozza M: Evaluation of the prognostic role of vascular endothelial growth factor and microvessel density in stages I and II breast cancer patients. Breast Cancer Res Treat 81(2): 159-168, 2003
13. Heimann R, Ferguson D, Gray S, Hellman S: Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis. Breast Cancer Res Treat 52(1-3): 147-158, 1998 (Review)
14. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM: Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60(12): 3183-3190, 2000
15. Mueller MD, Vigne JL, Minchenko A, Lebovic DI, Leitman DC, Taylor RN: Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc Natl Acad Sci USA 7(20): 10972-10977, 2000
16. Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M: Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 62(17): 4977-4984, 2002
17. Sengupta K, Banerjee S, Saxena N, Banerjee S: Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Int J Oncol 22(3): 609-14, 2003
18. Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S: Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene 23: 1052-1063, 2004
19. Poola I, Koduri S, Chatra S, Clark R: Identification of twenty alternatively spliced estrogen receptor alpha mRNAs in breast cancer cell lines and tumors using splice targeted primer approach. J. Steroid. Biochem Molbiol 72: 249-258, 2000
20. Murphy LC, Dotzlaw H: Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol Cell Endocrinol 3: 687-693, 1989
21. Miksicek RJ, Lei Y, Wang Y: Exon skipping gives rise to alternatively spliced forms of the estrogen receptor in breast tumor cells. Breast Cancer Res Treat 26(2): 163-174, 1993
22. Gotteland M, Desauty G, Delarue JC, Liu L, May E: Human estrogen receptor variants in both normal and neoplastic breast tissues. Mol Cell Endocrinol 112: 1-13, 1995
23. Pfeffer U, Fecarotta E, Vidali G: Coexpression of multiple estrogen receptor variant messenger RNAs in normal and neoplastic breast tissues and in MCF-7 cells. Cancer Res 55: 2158-2165, 1995
24. Leygue E, Huang AH, Murphy LC, Watson PH: Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res 56: 4324-4327, 1996
25. Jazaeri O, Shupnik MA, Jazaeri AA, Rice LW: Expression of estrogen receptor alpha mRNA and protein variants in human endometrial carcinoma. Gynecol Oncol 74(1): 38-47, 1999
26. Fasco MJ, Keyomarsi K, Arcaro KF, Gierthy JF: Expression of an estrogen receptor alpha variant protein in cell lines and tumors. Mol Cell Endocrinol 166(2): 156-169, 2000
27. Wang Y, Miksicek RJ: Identification of a dominant negative form of the estrogen receptor. Mol Endocrinol 5: 1707-1715, 1991
28. Poola I, Speirs V: Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues. J Steroid Biochem Mol Biol 78(5): 459-469, 2001
29. Bollig A, Miksicek RJ: An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription. Mol Endocrinol 14(5): 634-649, 2000
30. Umayahara Y, Kawamori R, Watada H, Imano E, Iwama N, Morishima T, Yamasaki Y, Kajimoto Y, Kamada T: Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J Biol Chem 269(23): 16433-16442, 1994
31. Kushner PJ, Agard DA, Greene GL, Scanlan TS, Shiau AK, Uht RM, Webb PJ: Estrogen receptor pathways to AP-1. Steroid Biochem Mol Biol 74: 311-317, 2000
32. Hyder SM, Murthy L, Stancel GM: Progestin regulation of vascular endothelial growth factor in human breast cancer. Cancer Res 58: 392-395, 1998
33. Goldhar AS, Vonderhaar BK, Trott JF, and Hovey RC: Prolactin-induced expression of vascular endothelial growth factor via Egr-1. Mol Cell Endocrinol 232(1-2): 9-19
34. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL: HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1 (HIF-1) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Mol Cell Biol 21: 3995-4004, 2001
35. Lopez-Ocejo O, Viloria-Petit A, Bequet-Romero M, Mukhopadhyay D, Rak J, Kerbel RS: Oncogenes and tumor angiogenesis: the HPV-16 E6 oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in a p53 independent manner. Oncogene 19: 4611-4620, 2000
36. Finkenzeller G, Sparacio A, Technau A, Marme D, Siemeister G: Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression. Oncogene 24: 669-676, 1997
37. Gille J, Swerlick RA, Caughman SW: Transforming growth factor-α induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivation. The EMBO J 16: 750-759, 1997
38. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H: Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21: 2000-2008, 2002
39. Koduri S, Poola I: Quantitation of alternatively spliced estrogen receptor alpha mRNAs as separate gene populations. Steroids 66(1): 17-23, 2001